ID   ADCYA_HUMAN             Reviewed;        1610 AA.
AC   Q96PN6; B4DZF0; F5GWS5; O95558; Q5R329; Q5R330; Q8WXV4; Q9NNX0;
DT   05-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   05-OCT-2010, sequence version 3.
DT   28-JUN-2023, entry version 171.
DE   RecName: Full=Adenylate cyclase type 10;
DE            EC=4.6.1.1 {ECO:0000269|PubMed:12609998, ECO:0000269|PubMed:15659711, ECO:0000269|PubMed:24567411, ECO:0000269|PubMed:24616449, ECO:0000269|PubMed:25040695};
DE   AltName: Full=AH-related protein;
DE   AltName: Full=Adenylate cyclase homolog;
DE   AltName: Full=Germ cell soluble adenylyl cyclase {ECO:0000303|PubMed:11423534};
DE            Short=hsAC;
DE            Short=sAC {ECO:0000303|PubMed:12609998, ECO:0000303|PubMed:25040695};
DE   AltName: Full=Testicular soluble adenylyl cyclase;
GN   Name=ADCY10; Synonyms=SAC;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT VAL-697.
RX   PubMed=11423534; DOI=10.1074/jbc.m011698200;
RA   Jaiswal B.S., Conti M.;
RT   "Identification and functional analysis of splice variants of the germ cell
RT   soluble adenylyl cyclase.";
RL   J. Biol. Chem. 276:31698-31708(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), TISSUE SPECIFICITY, INVOLVEMENT IN
RP   HCA2, AND VARIANT VAL-697.
RC   TISSUE=Intestine;
RX   PubMed=11932268; DOI=10.1210/jcem.87.4.8300;
RA   Reed B.Y., Gitomer W.L., Heller H.J., Hsu M.C., Lemke M., Padalino P.,
RA   Pak C.Y.C.;
RT   "Identification and characterization of a gene with base substitutions
RT   associated with the absorptive hypercalciuria phenotype and low spinal bone
RT   density.";
RL   J. Clin. Endocrinol. Metab. 87:1476-1485(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), COFACTOR, ACTIVITY REGULATION,
RP   BIOPHYSICOCHEMICAL PROPERTIES, CATALYTIC ACTIVITY, AND VARIANT VAL-697.
RX   PubMed=12609998; DOI=10.1074/jbc.m212475200;
RA   Litvin T.N., Kamenetsky M., Zarifyan A., Buck J., Levin L.R.;
RT   "Kinetic properties of 'soluble' adenylyl cyclase. Synergism between
RT   calcium and bicarbonate.";
RL   J. Biol. Chem. 278:15922-15926(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Khole V.V., Westbrook V.A., Mandal A., Herr J.C., Visconti P.E.;
RT   "Cloning of a human testicular soluble adenylyl cyclase.";
RL   Submitted (AUG-2000) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RA   Rhodes S.;
RL   Submitted (JAN-1999) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   SUBCELLULAR LOCATION.
RX   PubMed=12475901; DOI=10.1096/fj.02-0598fje;
RA   Zippin J.H., Chen Y., Nahirney P., Kamenetsky M., Wuttke M.S.,
RA   Fischman D.A., Levin L.R., Buck J.;
RT   "Compartmentalization of bicarbonate-sensitive adenylyl cyclase in distinct
RT   signaling microdomains.";
RL   FASEB J. 17:82-84(2003).
RN   [11]
RP   CATALYTIC ACTIVITY, COFACTOR, TISSUE SPECIFICITY, ACTIVITY REGULATION,
RP   SUBCELLULAR LOCATION, AND FUNCTION.
RX   PubMed=15659711; DOI=10.1152/ajpcell.00584.2004;
RA   Geng W., Wang Z., Zhang J., Reed B.Y., Pak C.Y.C., Moe O.W.;
RT   "Cloning and characterization of the human soluble adenylyl cyclase.";
RL   Am. J. Physiol. 288:C1305-C1316(2005).
RN   [12]
RP   FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=17591988; DOI=10.1085/jgp.200709784;
RA   Schmid A., Sutto Z., Nlend M.-C., Horvath G., Schmid N., Buck J.,
RA   Levin L.R., Conner G.E., Fregien N., Salathe M.;
RT   "Soluble adenylyl cyclase is localized to cilia and contributes to ciliary
RT   beat frequency regulation via production of cAMP.";
RL   J. Gen. Physiol. 130:99-109(2007).
RN   [13] {ECO:0007744|PDB:4OYA, ECO:0007744|PDB:4OYB, ECO:0007744|PDB:4OYI}
RP   X-RAY CRYSTALLOGRAPHY (1.70 ANGSTROMS) OF 1-469 IN COMPLEX WITH
RP   HYDROGENCARBONATE; CALCIUM AND ATP ANALOG, CATALYTIC ACTIVITY, FUNCTION,
RP   COFACTOR, AND DOMAIN.
RX   PubMed=24616449; DOI=10.1002/cmdc.201300480;
RA   Saalau-Bethell S.M., Berdini V., Cleasby A., Congreve M., Coyle J.E.,
RA   Lock V., Murray C.W., O'Brien M.A., Rich S.J., Sambrook T., Vinkovic M.,
RA   Yon J.R., Jhoti H.;
RT   "Crystal structure of human soluble adenylate cyclase reveals a distinct,
RT   highly flexible allosteric bicarbonate binding pocket.";
RL   ChemMedChem 9:823-832(2014).
RN   [14] {ECO:0007744|PDB:4UST, ECO:0007744|PDB:4USU, ECO:0007744|PDB:4USV}
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) OF 1-469 IN COMPLEXES WITH
RP   MAGNESIUM; CALCIUM; ATP AND ATP ANALOGS, FUNCTION, COFACTOR, CATALYTIC
RP   ACTIVITY, ACTIVITY REGULATION, AND DOMAIN.
RX   PubMed=25040695; DOI=10.1111/febs.12913;
RA   Kleinboelting S., van den Heuvel J., Steegborn C.;
RT   "Structural analysis of human soluble adenylyl cyclase and crystal
RT   structures of its nucleotide complexes-implications for cyclase catalysis
RT   and evolution.";
RL   FEBS J. 281:4151-4164(2014).
RN   [15] {ECO:0007744|PDB:4CLF, ECO:0007744|PDB:4CLK, ECO:0007744|PDB:4CLL}
RP   X-RAY CRYSTALLOGRAPHY (1.70 ANGSTROMS) OF 1-469 IN COMPLEX WITH CALCIUM;
RP   HYDROGENCARBONATE AND ATP ANALOGS, CATALYTIC ACTIVITY, COFACTOR, FUNCTION,
RP   ACTIVITY REGULATION, MUTAGENESIS OF LYS-95 AND ARG-176, AND DOMAIN.
RX   PubMed=24567411; DOI=10.1073/pnas.1322778111;
RA   Kleinboelting S., Diaz A., Moniot S., van den Heuvel J., Weyand M.,
RA   Levin L.R., Buck J., Steegborn C.;
RT   "Crystal structures of human soluble adenylyl cyclase reveal mechanisms of
RT   catalysis and of its activation through bicarbonate.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:3727-3732(2014).
CC   -!- FUNCTION: Catalyzes the formation of the signaling molecule cAMP
CC       (PubMed:12609998, PubMed:15659711, PubMed:24616449, PubMed:25040695,
CC       PubMed:24567411). May function as sensor that mediates responses to
CC       changes in cellular bicarbonate and CO(2) levels (PubMed:15659711,
CC       PubMed:17591988). Has a critical role in mammalian spermatogenesis by
CC       producing the cAMP which regulates cAMP-responsive nuclear factors
CC       indispensable for sperm maturation in the epididymis. Induces
CC       capacitation, the maturational process that sperm undergo prior to
CC       fertilization (By similarity). Involved in ciliary beat regulation
CC       (PubMed:17591988). {ECO:0000250|UniProtKB:Q8C0T9,
CC       ECO:0000269|PubMed:15659711, ECO:0000269|PubMed:17591988,
CC       ECO:0000269|PubMed:24567411, ECO:0000269|PubMed:24616449,
CC       ECO:0000269|PubMed:25040695}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP = 3',5'-cyclic AMP + diphosphate; Xref=Rhea:RHEA:15389,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, ChEBI:CHEBI:58165; EC=4.6.1.1;
CC         Evidence={ECO:0000269|PubMed:12609998, ECO:0000269|PubMed:15659711,
CC         ECO:0000269|PubMed:24567411, ECO:0000269|PubMed:24616449,
CC         ECO:0000269|PubMed:25040695};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:12609998, ECO:0000269|PubMed:15659711,
CC         ECO:0000269|PubMed:24567411, ECO:0000269|PubMed:25040695,
CC         ECO:0000305|PubMed:24616449};
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000269|PubMed:12609998, ECO:0000269|PubMed:15659711,
CC         ECO:0000269|PubMed:24616449};
CC       Note=Binds 2 magnesium ions per subunit (PubMed:25040695). Is also
CC       active with manganese (in vitro) (PubMed:12609998, PubMed:15659711,
CC       PubMed:24616449). {ECO:0000269|PubMed:12609998,
CC       ECO:0000269|PubMed:15659711, ECO:0000269|PubMed:24616449,
CC       ECO:0000305|PubMed:25040695};
CC   -!- ACTIVITY REGULATION: Activated by manganese or magnesium ions
CC       (PubMed:12609998, PubMed:24616449). In the presence of magnesium ions,
CC       the enzyme is activated by bicarbonate (PubMed:12609998,
CC       PubMed:15659711, PubMed:24567411). In the presence of manganese ions,
CC       the enzyme is inhibited by bicarbonate (PubMed:15659711). In the
CC       absence of magnesium and bicarbonate, the enzyme is weakly activated by
CC       calcium (PubMed:15659711). Calcium mildly increases the enzyme
CC       activity, also in the presence of magnesium ions (PubMed:15659711,
CC       PubMed:25040695). {ECO:0000269|PubMed:12609998,
CC       ECO:0000269|PubMed:15659711, ECO:0000269|PubMed:24567411,
CC       ECO:0000269|PubMed:24616449, ECO:0000269|PubMed:25040695}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.8 mM for ATP-Mn(2+) {ECO:0000269|PubMed:12609998};
CC         KM=2.41 mM for Mg(2+) {ECO:0000269|PubMed:12609998};
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:15659711};
CC       Peripheral membrane protein {ECO:0000269|PubMed:15659711}; Cytoplasmic
CC       side {ECO:0000269|PubMed:15659711}. Cytoplasm, cytoskeleton
CC       {ECO:0000269|PubMed:12475901, ECO:0000269|PubMed:15659711}. Cytoplasm,
CC       perinuclear region {ECO:0000269|PubMed:12475901,
CC       ECO:0000269|PubMed:15659711}. Nucleus {ECO:0000269|PubMed:12475901,
CC       ECO:0000269|PubMed:15659711}. Cell projection, cilium
CC       {ECO:0000269|PubMed:17591988}. Cytoplasm {ECO:0000269|PubMed:12475901}.
CC       Mitochondrion {ECO:0000269|PubMed:12475901}. Note=Distributed to
CC       subcellular compartments containing cAMP targets. Found as a plasma
CC       membrane-associated protein, protein concentrated in the perinuclear
CC       region and protein colocalized with actin or tubulin.
CC       {ECO:0000269|PubMed:12475901, ECO:0000269|PubMed:15659711}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q96PN6-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q96PN6-2; Sequence=VSP_030867;
CC       Name=3;
CC         IsoId=Q96PN6-3; Sequence=VSP_030866, VSP_030868, VSP_030869,
CC                                  VSP_030870;
CC       Name=4;
CC         IsoId=Q96PN6-4; Sequence=VSP_046329;
CC   -!- TISSUE SPECIFICITY: Detected in airway epithelial cells and testis (at
CC       protein level) (PubMed:17591988). Weakly expressed in multiple tissues.
CC       Expressed in brain, heart, kidney, liver, lung, pancreas, peripheral
CC       blood leukocytes, placenta, skeletal muscle, stomach, thymus, airway
CC       epithelial cells, duodenum, jejunum and ileum. Very low level of
CC       expression in bone. {ECO:0000269|PubMed:11932268,
CC       ECO:0000269|PubMed:15659711, ECO:0000269|PubMed:17591988}.
CC   -!- DOMAIN: The N-terminal guanylate cyclase domains are required for
CC       enzyme activity. Fragments or isoforms containing the first 470 amino
CC       acid residues are fully active. {ECO:0000269|PubMed:24567411,
CC       ECO:0000269|PubMed:24616449, ECO:0000269|PubMed:25040695}.
CC   -!- PTM: Cleavage may occur to generate the active 48 kDa form.
CC       {ECO:0000305}.
CC   -!- DISEASE: Hypercalciuria absorptive 2 (HCA2) [MIM:143870]: A common type
CC       of hypercalciuria, a condition characterized by excessive urinary
CC       calcium excretion. Absorptive hypercalciuria is due to gastrointestinal
CC       hyperabsorption of calcium and is a frequent cause of calcium oxalate
CC       nephrolithiasis. {ECO:0000269|PubMed:11932268}. Note=Disease
CC       susceptibility is associated with variants affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the adenylyl cyclase class-4/guanylyl cyclase
CC       family. {ECO:0000255|PROSITE-ProRule:PRU00099}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF271058; AAF74296.1; -; mRNA.
DR   EMBL; AF331033; AAL57036.1; -; mRNA.
DR   EMBL; AF176813; AAF65931.1; -; mRNA.
DR   EMBL; AF299350; AAK96045.1; -; mRNA.
DR   EMBL; AL035122; CAA22684.1; -; mRNA.
DR   EMBL; AK302884; BAG64062.1; -; mRNA.
DR   EMBL; Z97876; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z99943; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471067; EAW90804.1; -; Genomic_DNA.
DR   EMBL; CH471067; EAW90807.1; -; Genomic_DNA.
DR   EMBL; BC117366; AAI17367.1; -; mRNA.
DR   EMBL; BC117372; AAI17373.1; -; mRNA.
DR   CCDS; CCDS1265.1; -. [Q96PN6-1]
DR   CCDS; CCDS53426.1; -. [Q96PN6-4]
DR   CCDS; CCDS72977.1; -. [Q96PN6-2]
DR   RefSeq; NP_001161221.1; NM_001167749.2. [Q96PN6-4]
DR   RefSeq; NP_001284701.1; NM_001297772.1. [Q96PN6-2]
DR   RefSeq; NP_060887.2; NM_018417.5. [Q96PN6-1]
DR   RefSeq; XP_011508062.1; XM_011509760.2. [Q96PN6-1]
DR   PDB; 4CLF; X-ray; 1.70 A; A=1-469.
DR   PDB; 4CLK; X-ray; 2.20 A; A=1-469.
DR   PDB; 4CLL; X-ray; 1.70 A; A=1-469.
DR   PDB; 4CLP; X-ray; 1.90 A; A=1-469.
DR   PDB; 4CLS; X-ray; 1.85 A; A=1-469.
DR   PDB; 4CLT; X-ray; 1.95 A; A=1-469.
DR   PDB; 4CLU; X-ray; 1.90 A; A=1-469.
DR   PDB; 4CLW; X-ray; 2.15 A; A=1-469.
DR   PDB; 4CLY; X-ray; 2.05 A; A=1-469.
DR   PDB; 4CLZ; X-ray; 1.90 A; A=1-469.
DR   PDB; 4CM0; X-ray; 3.20 A; A=1-469.
DR   PDB; 4CM2; X-ray; 1.80 A; A=1-469.
DR   PDB; 4OYA; X-ray; 2.03 A; A=1-469.
DR   PDB; 4OYB; X-ray; 1.70 A; A=1-469.
DR   PDB; 4OYI; X-ray; 1.70 A; A=1-469.
DR   PDB; 4OYM; X-ray; 1.70 A; A=1-469.
DR   PDB; 4OYO; X-ray; 1.75 A; A=1-469.
DR   PDB; 4OYP; X-ray; 2.28 A; A=1-469.
DR   PDB; 4OYW; X-ray; 1.70 A; A=1-469.
DR   PDB; 4OYX; X-ray; 1.89 A; A=1-469.
DR   PDB; 4OYZ; X-ray; 1.74 A; A=1-469.
DR   PDB; 4OZ2; X-ray; 2.10 A; A=1-469.
DR   PDB; 4OZ3; X-ray; 1.70 A; A=1-469.
DR   PDB; 4UST; X-ray; 1.90 A; A=1-469.
DR   PDB; 4USU; X-ray; 1.95 A; A=1-469.
DR   PDB; 4USV; X-ray; 2.00 A; A=1-469.
DR   PDB; 4USW; X-ray; 2.05 A; A=1-469.
DR   PDB; 5D0R; X-ray; 2.24 A; A=1-469.
DR   PDB; 5IV3; X-ray; 1.86 A; A=1-469.
DR   PDB; 5IV4; X-ray; 1.79 A; A=1-469.
DR   PDB; 7OVD; X-ray; 2.20 A; A=1-469.
DR   PDB; 8B75; X-ray; 1.82 A; A=1-469.
DR   PDBsum; 4CLF; -.
DR   PDBsum; 4CLK; -.
DR   PDBsum; 4CLL; -.
DR   PDBsum; 4CLP; -.
DR   PDBsum; 4CLS; -.
DR   PDBsum; 4CLT; -.
DR   PDBsum; 4CLU; -.
DR   PDBsum; 4CLW; -.
DR   PDBsum; 4CLY; -.
DR   PDBsum; 4CLZ; -.
DR   PDBsum; 4CM0; -.
DR   PDBsum; 4CM2; -.
DR   PDBsum; 4OYA; -.
DR   PDBsum; 4OYB; -.
DR   PDBsum; 4OYI; -.
DR   PDBsum; 4OYM; -.
DR   PDBsum; 4OYO; -.
DR   PDBsum; 4OYP; -.
DR   PDBsum; 4OYW; -.
DR   PDBsum; 4OYX; -.
DR   PDBsum; 4OYZ; -.
DR   PDBsum; 4OZ2; -.
DR   PDBsum; 4OZ3; -.
DR   PDBsum; 4UST; -.
DR   PDBsum; 4USU; -.
DR   PDBsum; 4USV; -.
DR   PDBsum; 4USW; -.
DR   PDBsum; 5D0R; -.
DR   PDBsum; 5IV3; -.
DR   PDBsum; 5IV4; -.
DR   PDBsum; 7OVD; -.
DR   PDBsum; 8B75; -.
DR   AlphaFoldDB; Q96PN6; -.
DR   SMR; Q96PN6; -.
DR   BioGRID; 120921; 3.
DR   IntAct; Q96PN6; 1.
DR   STRING; 9606.ENSP00000356825; -.
DR   BindingDB; Q96PN6; -.
DR   ChEMBL; CHEMBL5854; -.
DR   DrugBank; DB02587; Colforsin.
DR   GuidetoPHARMACOLOGY; 3068; -.
DR   GlyGen; Q96PN6; 3 sites, 1 O-linked glycan (3 sites).
DR   iPTMnet; Q96PN6; -.
DR   PhosphoSitePlus; Q96PN6; -.
DR   SwissPalm; Q96PN6; -.
DR   BioMuta; ADCY10; -.
DR   DMDM; 308153637; -.
DR   EPD; Q96PN6; -.
DR   MassIVE; Q96PN6; -.
DR   PaxDb; Q96PN6; -.
DR   PeptideAtlas; Q96PN6; -.
DR   ProteomicsDB; 24204; -.
DR   ProteomicsDB; 77715; -. [Q96PN6-1]
DR   ProteomicsDB; 77716; -. [Q96PN6-2]
DR   ProteomicsDB; 77717; -. [Q96PN6-3]
DR   Antibodypedia; 3017; 165 antibodies from 24 providers.
DR   DNASU; 55811; -.
DR   Ensembl; ENST00000367848.1; ENSP00000356822.1; ENSG00000143199.18. [Q96PN6-2]
DR   Ensembl; ENST00000367851.9; ENSP00000356825.4; ENSG00000143199.18. [Q96PN6-1]
DR   Ensembl; ENST00000545172.5; ENSP00000441992.1; ENSG00000143199.18. [Q96PN6-4]
DR   GeneID; 55811; -.
DR   KEGG; hsa:55811; -.
DR   MANE-Select; ENST00000367851.9; ENSP00000356825.4; NM_018417.6; NP_060887.2.
DR   UCSC; uc001ger.4; human. [Q96PN6-1]
DR   AGR; HGNC:21285; -.
DR   CTD; 55811; -.
DR   DisGeNET; 55811; -.
DR   GeneCards; ADCY10; -.
DR   HGNC; HGNC:21285; ADCY10.
DR   HPA; ENSG00000143199; Group enriched (liver, testis).
DR   MalaCards; ADCY10; -.
DR   MIM; 143870; phenotype.
DR   MIM; 605205; gene.
DR   neXtProt; NX_Q96PN6; -.
DR   OpenTargets; ENSG00000143199; -.
DR   Orphanet; 2197; Idiopathic hypercalciuria.
DR   PharmGKB; PA162375618; -.
DR   VEuPathDB; HostDB:ENSG00000143199; -.
DR   eggNOG; ENOG502QPPT; Eukaryota.
DR   GeneTree; ENSGT00390000001322; -.
DR   HOGENOM; CLU_004055_1_0_1; -.
DR   InParanoid; Q96PN6; -.
DR   OMA; HCRSGDF; -.
DR   OrthoDB; 3076794at2759; -.
DR   PhylomeDB; Q96PN6; -.
DR   TreeFam; TF329284; -.
DR   BRENDA; 4.6.1.1; 2681.
DR   PathwayCommons; Q96PN6; -.
DR   Reactome; R-HSA-5610787; Hedgehog 'off' state.
DR   SABIO-RK; Q96PN6; -.
DR   SignaLink; Q96PN6; -.
DR   SIGNOR; Q96PN6; -.
DR   BioGRID-ORCS; 55811; 8 hits in 1145 CRISPR screens.
DR   ChiTaRS; ADCY10; human.
DR   GeneWiki; ADCY10; -.
DR   GenomeRNAi; 55811; -.
DR   Pharos; Q96PN6; Tchem.
DR   PRO; PR:Q96PN6; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; Q96PN6; protein.
DR   Bgee; ENSG00000143199; Expressed in sperm and 99 other tissues.
DR   ExpressionAtlas; Q96PN6; baseline and differential.
DR   Genevisible; Q96PN6; HS.
DR   GO; GO:0016324; C:apical plasma membrane; IEA:Ensembl.
DR   GO; GO:0045178; C:basal part of cell; IEA:Ensembl.
DR   GO; GO:0005929; C:cilium; IEA:UniProtKB-SubCell.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; NAS:UniProtKB.
DR   GO; GO:0030425; C:dendrite; IEA:Ensembl.
DR   GO; GO:0005576; C:extracellular region; IEA:GOC.
DR   GO; GO:0030426; C:growth cone; IEA:Ensembl.
DR   GO; GO:0005739; C:mitochondrion; IEA:UniProtKB-SubCell.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:UniProtKB.
DR   GO; GO:0004016; F:adenylate cyclase activity; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0051117; F:ATPase binding; IEA:Ensembl.
DR   GO; GO:0071890; F:bicarbonate binding; IDA:UniProtKB.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:InterPro.
DR   GO; GO:0030145; F:manganese ion binding; IEA:Ensembl.
DR   GO; GO:0006171; P:cAMP biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0071241; P:cellular response to inorganic substance; IDA:UniProtKB.
DR   GO; GO:0003351; P:epithelial cilium movement involved in extracellular fluid movement; IMP:UniProtKB.
DR   GO; GO:0035556; P:intracellular signal transduction; IEA:InterPro.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl.
DR   GO; GO:0007283; P:spermatogenesis; IEA:InterPro.
DR   CDD; cd07302; CHD; 2.
DR   Gene3D; 3.30.70.1230; Nucleotide cyclase; 2.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 1.
DR   InterPro; IPR001054; A/G_cyclase.
DR   InterPro; IPR016577; Adenylate_cyclase_typ10.
DR   InterPro; IPR029787; Nucleotide_cyclase.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR16305:SF32; ADENYLATE CYCLASE TYPE 10; 1.
DR   PANTHER; PTHR16305; TESTICULAR SOLUBLE ADENYLYL CYCLASE; 1.
DR   Pfam; PF00211; Guanylate_cyc; 2.
DR   PIRSF; PIRSF011131; Soluble_adenylyl_cyclase; 1.
DR   SUPFAM; SSF55073; Nucleotide cyclase; 2.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
DR   PROSITE; PS50125; GUANYLATE_CYCLASE_2; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; cAMP biosynthesis;
KW   Cell membrane; Cell projection; Cytoplasm; Cytoskeleton; Lyase; Magnesium;
KW   Manganese; Membrane; Metal-binding; Mitochondrion; Nucleotide-binding;
KW   Nucleus; Reference proteome; Repeat.
FT   CHAIN           1..1610
FT                   /note="Adenylate cyclase type 10"
FT                   /id="PRO_0000317101"
FT   DOMAIN          42..179
FT                   /note="Guanylate cyclase 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00099"
FT   DOMAIN          293..418
FT                   /note="Guanylate cyclase 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00099"
FT   BINDING         47..52
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000269|PubMed:25040695,
FT                   ECO:0000305|PubMed:24567411, ECO:0000305|PubMed:24616449,
FT                   ECO:0007744|PDB:4USW"
FT   BINDING         47
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00099,
FT                   ECO:0000269|PubMed:25040695, ECO:0000305|PubMed:24567411,
FT                   ECO:0000305|PubMed:24616449"
FT   BINDING         47
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00099"
FT   BINDING         48
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00099"
FT   BINDING         95
FT                   /ligand="hydrogencarbonate"
FT                   /ligand_id="ChEBI:CHEBI:17544"
FT                   /evidence="ECO:0000269|PubMed:24567411,
FT                   ECO:0000269|PubMed:24616449, ECO:0007744|PDB:4CLL,
FT                   ECO:0007744|PDB:4OYZ"
FT   BINDING         99
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000269|PubMed:25040695,
FT                   ECO:0000305|PubMed:24567411, ECO:0000305|PubMed:24616449,
FT                   ECO:0007744|PDB:4USW"
FT   BINDING         99
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00099,
FT                   ECO:0000269|PubMed:25040695, ECO:0000305|PubMed:24567411,
FT                   ECO:0000305|PubMed:24616449"
FT   BINDING         99
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00099"
FT   BINDING         144
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000269|PubMed:25040695,
FT                   ECO:0000305|PubMed:24567411, ECO:0000305|PubMed:24616449,
FT                   ECO:0007744|PDB:4USW"
FT   BINDING         167
FT                   /ligand="hydrogencarbonate"
FT                   /ligand_id="ChEBI:CHEBI:17544"
FT                   /evidence="ECO:0000269|PubMed:24567411,
FT                   ECO:0000269|PubMed:24616449, ECO:0007744|PDB:4CLL,
FT                   ECO:0007744|PDB:4OYZ"
FT   BINDING         176
FT                   /ligand="hydrogencarbonate"
FT                   /ligand_id="ChEBI:CHEBI:17544"
FT                   /evidence="ECO:0000269|PubMed:24567411,
FT                   ECO:0000269|PubMed:24616449, ECO:0007744|PDB:4CLL,
FT                   ECO:0007744|PDB:4OYZ"
FT   BINDING         337
FT                   /ligand="hydrogencarbonate"
FT                   /ligand_id="ChEBI:CHEBI:17544"
FT                   /evidence="ECO:0000269|PubMed:24567411,
FT                   ECO:0000269|PubMed:24616449, ECO:0007744|PDB:4CLL,
FT                   ECO:0007744|PDB:4OYZ"
FT   BINDING         406
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000269|PubMed:25040695,
FT                   ECO:0000305|PubMed:24567411, ECO:0000305|PubMed:24616449,
FT                   ECO:0007744|PDB:4USW"
FT   BINDING         412..416
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000305|PubMed:24567411,
FT                   ECO:0000305|PubMed:24616449, ECO:0000305|PubMed:25040695"
FT   VAR_SEQ         1..1099
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|Ref.5"
FT                   /id="VSP_030866"
FT   VAR_SEQ         1..153
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_046329"
FT   VAR_SEQ         1..97
FT                   /note="MNTPKEEFQDWPIVRIAAHLPDLIVYGHFSPERPFMDYFDGVLMFVDISGFT
FT                   AMTEKFSSAMYMDRGAEQLVEILNYHISAIVEKVLIFGGDILKFA -> MSLSE (in
FT                   isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11932268"
FT                   /id="VSP_030867"
FT   VAR_SEQ         1100..1103
FT                   /note="DNYM -> MLFK (in isoform 3)"
FT                   /evidence="ECO:0000303|Ref.5"
FT                   /id="VSP_030868"
FT   VAR_SEQ         1430..1471
FT                   /note="YARLQEWDNFYKFSNRAKNLLPRRTMTLTYYDGISRYMEGQV -> ECEAGV
FT                   GRRLHTSRDPGMPDFRNGTTFTNFPIELKIFCQEEP (in isoform 3)"
FT                   /evidence="ECO:0000303|Ref.5"
FT                   /id="VSP_030869"
FT   VAR_SEQ         1472..1610
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|Ref.5"
FT                   /id="VSP_030870"
FT   VARIANT         234
FT                   /note="T -> M (in dbSNP:rs16859886)"
FT                   /id="VAR_038476"
FT   VARIANT         697
FT                   /note="I -> V (in dbSNP:rs2071921)"
FT                   /evidence="ECO:0000269|PubMed:11423534,
FT                   ECO:0000269|PubMed:11932268, ECO:0000269|PubMed:12609998"
FT                   /id="VAR_038477"
FT   MUTAGEN         95
FT                   /note="K->A: Nearly abolishes bicarbonate-mediated increase
FT                   of enzyme activity. Abolishes bicarbonate-mediated increase
FT                   of enzyme activity; when associated with A-176."
FT                   /evidence="ECO:0000269|PubMed:24567411"
FT   MUTAGEN         176
FT                   /note="R->A: Reduces bicarbonate-mediated increase of
FT                   enzyme activity. Abolishes bicarbonate-mediated increase of
FT                   enzyme activity; when associated with A-95."
FT                   /evidence="ECO:0000269|PubMed:24567411"
FT   CONFLICT        942
FT                   /note="L -> P (in Ref. 6; BAG64062)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1359
FT                   /note="L -> P (in Ref. 4; AAK96045)"
FT                   /evidence="ECO:0000305"
FT   HELIX           12..17
FT                   /evidence="ECO:0007829|PDB:4CLF"
FT   HELIX           22..25
FT                   /evidence="ECO:0007829|PDB:4CLF"
FT   STRAND          33..47
FT                   /evidence="ECO:0007829|PDB:4CLF"
FT   HELIX           49..52
FT                   /evidence="ECO:0007829|PDB:4CLF"
FT   HELIX           55..59
FT                   /evidence="ECO:0007829|PDB:4CLF"
FT   HELIX           61..63
FT                   /evidence="ECO:0007829|PDB:4CLF"
FT   HELIX           67..88
FT                   /evidence="ECO:0007829|PDB:4CLF"
FT   STRAND          92..96
FT                   /evidence="ECO:0007829|PDB:4CLF"
FT   STRAND          98..106
FT                   /evidence="ECO:0007829|PDB:4CLF"
FT   HELIX           109..111
FT                   /evidence="ECO:0007829|PDB:4CLF"
FT   HELIX           112..129
FT                   /evidence="ECO:0007829|PDB:4CLF"
FT   TURN            130..132
FT                   /evidence="ECO:0007829|PDB:4OYB"
FT   STRAND          135..138
FT                   /evidence="ECO:0007829|PDB:4OYB"
FT   STRAND          144..158
FT                   /evidence="ECO:0007829|PDB:4CLF"
FT   STRAND          163..169
FT                   /evidence="ECO:0007829|PDB:4CLF"
FT   HELIX           170..181
FT                   /evidence="ECO:0007829|PDB:4CLF"
FT   STRAND          187..189
FT                   /evidence="ECO:0007829|PDB:4CLF"
FT   HELIX           191..196
FT                   /evidence="ECO:0007829|PDB:4CLF"
FT   HELIX           199..201
FT                   /evidence="ECO:0007829|PDB:4CLF"
FT   STRAND          202..207
FT                   /evidence="ECO:0007829|PDB:4CLF"
FT   STRAND          210..218
FT                   /evidence="ECO:0007829|PDB:4CLF"
FT   HELIX           226..234
FT                   /evidence="ECO:0007829|PDB:4CLF"
FT   HELIX           243..245
FT                   /evidence="ECO:0007829|PDB:4CLF"
FT   HELIX           251..254
FT                   /evidence="ECO:0007829|PDB:4CLF"
FT   HELIX           259..266
FT                   /evidence="ECO:0007829|PDB:4CLF"
FT   HELIX           271..277
FT                   /evidence="ECO:0007829|PDB:4CLF"
FT   TURN            283..286
FT                   /evidence="ECO:0007829|PDB:4CLF"
FT   STRAND          288..302
FT                   /evidence="ECO:0007829|PDB:4CLF"
FT   HELIX           307..327
FT                   /evidence="ECO:0007829|PDB:4CLF"
FT   STRAND          331..337
FT                   /evidence="ECO:0007829|PDB:4CLF"
FT   STRAND          339..349
FT                   /evidence="ECO:0007829|PDB:4CLF"
FT   TURN            351..353
FT                   /evidence="ECO:0007829|PDB:4OYW"
FT   HELIX           358..374
FT                   /evidence="ECO:0007829|PDB:4CLF"
FT   STRAND          379..398
FT                   /evidence="ECO:0007829|PDB:4CLF"
FT   STRAND          401..408
FT                   /evidence="ECO:0007829|PDB:4CLF"
FT   HELIX           409..420
FT                   /evidence="ECO:0007829|PDB:4CLF"
FT   STRAND          424..427
FT                   /evidence="ECO:0007829|PDB:4CLF"
FT   HELIX           429..435
FT                   /evidence="ECO:0007829|PDB:4CLF"
FT   HELIX           439..441
FT                   /evidence="ECO:0007829|PDB:4CLF"
FT   STRAND          442..444
FT                   /evidence="ECO:0007829|PDB:4CLF"
FT   STRAND          460..462
FT                   /evidence="ECO:0007829|PDB:4CLF"
FT   STRAND          465..467
FT                   /evidence="ECO:0007829|PDB:4OYZ"
SQ   SEQUENCE   1610 AA;  187149 MW;  E0E205747120EFE0 CRC64;
     MNTPKEEFQD WPIVRIAAHL PDLIVYGHFS PERPFMDYFD GVLMFVDISG FTAMTEKFSS
     AMYMDRGAEQ LVEILNYHIS AIVEKVLIFG GDILKFAGDA LLALWRVERK QLKNIITVVI
     KCSLEIHGLF ETQEWEEGLD IRVKIGLAAG HISMLVFGDE THSHFLVIGQ AVDDVRLAQN
     MAQMNDVILS PNCWQLCDRS MIEIESVPDQ RAVKVNFLKP PPNFNFDEFF TKCTTFMHYY
     PSGEHKNLLR LACTLKPDPE LEMSLQKYVM ESILKQIDNK QLQGYLSELR PVTIVFVNLM
     FEDQDKAEEI GPAIQDAYMH ITSVLKIFQG QINKVFMFDK GCSFLCVFGF PGEKVPDELT
     HALECAMDIF DFCSQVHKIQ TVSIGVASGI VFCGIVGHTV RHEYTVIGQK VNLAARMMMY
     YPGIVTCDSV TYNGSNLPAY FFKELPKKVM KGVADSGPLY QYWGRTEKVM FGMACLICNR
     KEDYPLLGRN KEINYFMYTM KKFLISNSSQ VLMYEGLPGY GKSQILMKIE YLAQGKNHRI
     IAISLNKISF HQTFYTIQMF MANVLGLDTC KHYKERQTNL RNKVMTLLDE KFYCLLNDIF
     HVQFPISREI SRMSTLKKQK QLEILFMKIL KLIVKEERII FIIDEAQFVD STSWRFMEKL
     IRTLPIFIIM SLCPFVNIPC AAARAVIKNR NTTYIVIGAV QPNDISNKIC LDLNVSCISK
     ELDSYLGEGS CGIPFYCEEL LKNLEHHEVL VFQQTESEEK TNRTWNNLFK YSIKLTEKLN
     MVTLHSDKES EEVCHLTSGV RLKNLSPPTS LKEISLIQLD SMRLSHQMLV RCAAIIGLTF
     TTELLFEILP CWNMKMMIKT LATLVESNIF YCFRNGKELQ KALKQNDPSF EVHYRSLSLK
     PSEGMDHGEE EQLRELENEV IECHRIRFCN PMMQKTAYEL WLKDQRKAMH LKCARFLEED
     AHRCDHCRGR DFIPYHHFTV NIRLNALDMD AIKKMAMSHG FKTEEKLILS NSEIPETSAF
     FPENRSPEEI REKILNFFDH VLTKMKTSDE DIIPLESCQC EEILEIVILP LAHHFLALGE
     NDKALYYFLE IASAYLIFCD NYMAYMYLNE GQKLLKTLKK DKSWSQTFES ATFYSLKGEV
     CFNMGQIVLA KKMLRKALKL LNRIFPYNLI SLFLHIHVEK NRHFHYVNRQ AQESPPPGKK
     RLAQLYRQTV CLSLLWRIYS YSYLFHCKYY AHLAVMMQMN TALETQNCFQ IIKAYLDYSL
     YHHLAGYKGV WFKYEVMAME HIFNLPLKGE GIEIVAYVAE TLVFNKLIMG HLDLAIELGS
     RALQMWALLQ NPNRHYQSLC RLSRCLLLNS RYPQLIQVLG RLWELSVTQE HIFSKAFFYF
     VCLDILLYSG FVYRTFEECL EFIHQYENNR ILKFHSGLLL GLYSSVAIWY ARLQEWDNFY
     KFSNRAKNLL PRRTMTLTYY DGISRYMEGQ VLHLQKQIKE QSENAQASGE ELLKNLENLV
     AQNTTGPVFC PRLYHLMAYV CILMGDGQKC GLFLNTALRL SETQGNILEK CWLNMNKESW
     YSTSELKEDQ WLQTILSLPS WEKIVAGRVN IQDLQKNKFL MRANTVDNHF
//
